Healthcare Stocks Cardiol Therapeutics’ Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association Results demonstrate CardiolRx™ may represent a paradigm shift in the treatment of… Ryan AllwayMay 7, 2026
Feature Healthcare Stocks Top News Ventyx/Lilly Deal Shows the Value of Anti-inflammatory Drugs We wrote late last year about the recent upswing in big pharma… Robin LeffertsJanuary 15, 2026
Feature Healthcare Stocks Top News Phase II Results Point the Way Forward for Cardiol Therapeutics For smaller public company drug developers clinical trial results are major catalytic… Robin LeffertsSeptember 16, 2025
Feature Healthcare Stocks Understanding the Importance of Left Ventricular Mass in Heart Conditions Left ventricular (LV) mass has emerged as one of the most powerful… Robin LeffertsSeptember 15, 2025
